Benzinga | Aug 5, 2020 04:01PM EDT

Immunomedics Q4 EPS $(0.73) Misses $(0.35) Estimate, Sales $20.07M Beat $12.91M Estimate

Immunomedics (NASDAQ:IMMU) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.35) by 108.57 percent. This is a 82.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $20.07 million which beat the analyst consensus estimate of $12.91 million by 55.49 percent.